GlassScriptPhysician profile
Jane T Luu
NPI 1124281423
$3,927.47
in general payments reported to CMS, 2019-2025
7 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,370 · 2020: $35.18 · 2021: $73.44 · 2022: $94.18 · 2023: $135 · 2024: $53.75 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,797.69 | 2019-2022 | |
| Boston Scientific Corporation | $1,733.09 | 2019-2024 | Patientcare Link |
| Edwards Lifesciences Corporation | $186.40 | 2019-2023 | Sapien 3 Ultra Resilia |
| Teleflex LLC | $120.48 | 2025 | Guideliner |
| Novartis Pharmaceuticals Corporation | $38.95 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.87 | 2025 | Lifevest |
| Shockwave Medical, INC | $20.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.